BeStock  
Stocks › Biotechnology › GERN

Geron GERN

US equityMarket cap rank #3434Biotechnology
$1.20 −$0.01 (-0.83%)
Pre-market · Oct 8, 8:50 am ET · After hours $1.20 0.00%
Open$1.21
Prev close$1.21
Day range$1.19 – $1.22
Volume5.14M
Market cap$770.97M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-10.9x
CheapRich

Below its usual level · 30th percentile, 5-year average -8.4x

Price / book3.5x
CheapRich

Below its usual level · 28th percentile, 5-year average 5.5x

#3886 of 5317 stocks by PB (1 = cheapest)

Price / sales3.8x
CheapRich

Near the bottom of its 5-year range · 1st percentile, 5-year average 1,399.6x

#3474 of 5146 stocks by PS (1 = cheapest)

P/E over five years

-16x-11x-7x-2xOct '21Apr '24Oct '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$1.30
Price vs. fair value-7.4%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 3.53 – 5.52 28% (cheaper than usual) #3886 of 5317 (1 = cheapest)
PE -10.91 104.86 -8.43 30% (cheaper than usual) –
PS 3.77 2.69 1,399.63 1% (cheaper than usual) #3474 of 5146 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★
Fair value estimate$1.30
Economic moatNone
UncertaintyHigh

Discussion

No comments yet — be the first to weigh in on GERN.

Leave a comment

Scroll to Top